Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A Prospective Blinded Study of Endoscopic Ultrasound Elastography in Liver Disease: Towards a Virtual Biopsy.

Schulman AR, Lin MV, Rutherford A, Chan WW, Ryou M.

Clin Endosc. 2018 Mar;51(2):181-185. doi: 10.5946/ce.2017.095. Epub 2018 Mar 23.

2.

Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD.

Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1615-1623. doi: 10.2215/CJN.02510317. Epub 2017 Sep 7.

3.

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV.

PLoS One. 2016 Jul 14;11(7):e0158431. doi: 10.1371/journal.pone.0158431. eCollection 2016.

4.

Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.

Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RT.

Clin Transplant. 2016 Apr;30(4):452-60. doi: 10.1111/ctr.12710. Epub 2016 Mar 1.

5.

Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.

Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT.

Hepatology. 2016 Feb;63(2):408-17. doi: 10.1002/hep.28297. Epub 2015 Dec 11.

6.

Enhancing our understanding of current therapies for hepatitis C virus (HCV).

Gogela NA, Lin MV, Wisocky JL, Chung RT.

Curr HIV/AIDS Rep. 2015 Mar;12(1):68-78. doi: 10.1007/s11904-014-0243-7. Review.

7.

Hepatitis C virus-associated cancer.

Lin MV, King LY, Chung RT.

Annu Rev Pathol. 2015;10:345-70. doi: 10.1146/annurev-pathol-012414-040323. Epub 2014 Nov 5. Review.

PMID:
25387053
8.

Hepatitis C virus NS3 mutations in haemophiliacs.

Lin MV, Charlton AN, Rouster SD, Zamor PJ, Sherman KE.

Haemophilia. 2014 Sep;20(5):659-65. doi: 10.1111/hae.12420. Epub 2014 Apr 3.

9.

Recent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment.

Lin MV, Chung R.

Clin Liver Dis (Hoboken). 2014 Apr 1;3(3):65-68. doi: 10.1002/cld.332. eCollection 2014 Mar. No abstract available.

10.

Papillary thyroid cancer and inflammatory bowel disease: is there a relationship?

Sonu IS, Blonski W, Lin MV, Lewis J, Aberra F, Lichtenstein GR.

World J Gastroenterol. 2013 Feb 21;19(7):1079-84. doi: 10.3748/wjg.v19.i7.1079.

11.

The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease.

Lin MV, Blonski W, Buchner AM, Reddy KR, Lichtenstein GR.

Dig Dis Sci. 2013 Apr;58(4):1149-56. doi: 10.1007/s10620-012-2457-0. Epub 2012 Nov 20. Review.

PMID:
23179145
12.

Clinical pharmacology of 5-ASA compounds in inflammatory bowel disease.

Sonu I, Lin MV, Blonski W, Lichtenstein GR.

Gastroenterol Clin North Am. 2010 Sep;39(3):559-99. doi: 10.1016/j.gtc.2010.08.011. Review.

PMID:
20951918
13.

A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.

Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, Sampat S, Mendizabal M, Lin MV, Lichtenstein GR.

Clin Gastroenterol Hepatol. 2011 Jan;9(1):36-41.e1. doi: 10.1016/j.cgh.2010.09.016. Epub 2010 Oct 1. Review.

PMID:
20888436
14.

An approach to the management of refractory ulcerative colitis.

Sonu I, Blonski W, Lin MV, Lichtenstein GR.

Minerva Gastroenterol Dietol. 2010 Jun;56(2):213-31. Review.

PMID:
20485258
15.

What is the optimal therapy for Crohn's disease: step-up or top-down?

Lin MV, Blonski W, Lichtenstein GR.

Expert Rev Gastroenterol Hepatol. 2010 Apr;4(2):167-80. doi: 10.1586/egh.10.4. Review.

PMID:
20350264
16.

Diabetic ketoacidosis in type 2 diabetics: a novel presentation of pancreatic adenocarcinoma.

Lin MV, Bishop G, Benito-Herrero M.

J Gen Intern Med. 2010 Apr;25(4):369-73. doi: 10.1007/s11606-009-1237-9. Epub 2010 Jan 30.

Supplemental Content

Support Center